WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Antidepressant Medication: How Long Is Enough?

Comments (1)

When doctors first began prescribing antidepressant medications in the 1950s, the prevailing belief was that a short course of medication could cure depression -- much like antibiotics wipe out an infection. But over time, physicians began to realize that depression required longer treatment regimens than originally thought.

Today, experts recognize that major depression and anxiety are long term, often recurrent illnesses. But it isn't necessarily permanent, and many people with mood disorders can eventually stop taking antidepressant medication.

Although antidepressant medications aren't addictive and, when discontinued, don't cause the same type of withdrawal reaction as medications like opiates for pain, your body may still experience withdrawal-like symptoms. If you quit antidepressant medication cold turkey, you could experience physical discomfort or a relapse of your condition. Some people can be tapered off antidepressant medication after an extended period of stability, but these changes need to be timed carefully.

Antidepressant medications usually produce a significant improvement in four to six weeks, although it may take 12 weeks or longer on a therapeutic dose to see the full benefit; this is known as the acute phase. If your condition has improved after this time, you move on to a continuation phase with the goal of preventing a relapse (the return of the same depressive episode).

Continuation treatment lasts anywhere from four months to a year, and you will continue to take the same dosage of the antidepressant medication that worked in the acute phase. If you remain symptom free at the end of the continuation phase, you are recovered, and many people require no further treatment.

Your doctor may prescribe slightly lower doses of your antidepressant medication in the maintenance phase than during the acute or continuation phases. Maintenance treatment may be especially important for older adults, for whom research indicates high rates of recurrence: 50 to 90% over a two- to three-year period, as cited by a study in The New England Journal of Medicine. To assess whether maintenance treatment could ward off recurrence, this study found that people ages 70 and older who took the selective serotonin reuptake inhibitor (SSRI) paroxetine (Paxil) for two years after successful continuation treatment were almost two and a half times less likely to have a recurrence than those who took a placebo during this time.

Despite these guidelines, there is no "one size fits all" when it comes to treatment length. However, recent evidence shows that many people require a year or more of antidepressant therapy to treat a major episode of depression or anxiety adequately.

Posted in Depression and Anxiety on February 24, 2010
Reviewed January 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Depression and Anxiety Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Women must stand up to big pharma’s bullying them to over-medicate with antidepressants washing out their emotions & personalities and interfering being mothers, sisters, brothers, daughters, partners and lovers.. Women are targeted for antidepressants by big Pharma in the same way that tobacco companies targeted us 70 years ago. Drug companies are so effective at selling unhappiness to women that women take more than twice as many antidepressants as men. http://sadnessaddiction.blogspot.com/

Posted by: sadnessaddiction | March 24, 2010 12:21 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Managing Bipolar Disorder

If you or a loved one has bipolar disorder, you know first-hand what it’s like to live with the ups and downs of this serious mood disorder. The good news is that when properly diagnosed it can be managed effectively with medications and other therapies. That’s why Karen Swartz, M.D and a team of world-famous psychiatrists at Johns Hopkins have gathered together to write Managing Bipolar Disorder. Managing Bipolar Disorder provides the latest thinking on the causes of bipolar disorder and the full range of your treatment options -- including medications and electroconvulsive therapy. This authoritative 70-page special report contains current information you won’t find in any other single source. Read more or order Managing Bipolar Disorder Digital Report




Johns Hopkins White Papers

The 2011 Johns Hopkins White Papers

Depression and Anxiety White Paper— Mood Disorders, Bipolar Disorder (Manic Depression), Phobias, more.

Read More or Order.



The Johns Hopkins Medical Letter: Health After 50

Since 1988, Hopkins experts have been reporting on the latest cutting edge information on treating the major medical conditions affecting the over 50s. Women's health, men's medical concerns, nutrition, weight control, breakthroughs on diabetes, and more, mailed directly to you every month from our specialists.

Read more, or order now and receive two FREE Special Reports...